Acadia Healthcare (ACHC) Projected to Post Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is anticipated to issue its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $800.0990 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 9:00 AM ET.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $16.79 on Monday. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $42.85. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. The business has a 50 day moving average price of $14.23 and a 200-day moving average price of $18.52. The company has a market cap of $1.55 billion, a PE ratio of 14.35, a price-to-earnings-growth ratio of 4.78 and a beta of 0.89.

Analyst Ratings Changes

ACHC has been the topic of several recent analyst reports. Bank of America cut Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $21.50 to $13.00 in a research note on Wednesday, December 3rd. UBS Group dropped their price target on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Raymond James Financial set a $17.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. KeyCorp decreased their price objective on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd. Finally, Barclays cut their target price on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 4th. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.62.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC grew its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Federated Hermes Inc. grew its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after buying an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Acadia Healthcare by 2.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its position in shares of Acadia Healthcare by 2.1% during the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.